Hjem › Inflammatorisk tarmsygdom › New York
Inflammatorisk tarmsygdom kliniske forsøg i New York
21 studier for Inflammatorisk tarmsygdom søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Ellipsis Research Group, Brooklyn
- Smart Medical Research - Jackson Heights, Jackson Heights
- Pioneer Clinical Research NY, New York
- og 1 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 30. sep. 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Albany
- Xencor Investigative Site, Rochester
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 037, New York
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-002, Albany
- Site US-016, Rochester
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 25. sep. 2026 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- og 1 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Icahn School of Medicine at Mount Sinai, New York
RekruttererFase 3
Alder 2 til 19 · Alle køn · Opdateret 22. sep. 2026 · NCT04844606A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
- Digestive Disease Medicine of Central New York, Utica
RekruttererFase 4
3 Weeks · Kvinder · Opdateret 8. sep. 2026 · NCT07612267A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 24. aug. 2026 · NCT05509777Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
- Weill Cornell Medicine, New York
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT06274554BOOM-IBD2 Pivotal Clinical Trial
- Northwell Health North Shore University Hospital, Manhasset
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 6. aug. 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- New York University, New York
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07237516Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore Hutchinson Campus, The Bronx
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT06266663Low Dose IL-2 for the Treatment of Crohn's Disease
- Mount Sinai, New York
RekruttererFase 1/2
Alder 12 til 80 · Alle køn · Opdateret 3. aug. 2026 · NCT04263831Autologous Stem Cell Transplant for Crohn's Disease
- Icahn School of Medicine at Mount Sinai, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT03219359Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Cohen Children's Medical Center of NY, Lake Success
- Columbia University Medical Center, New York
RekruttererFase 4
Alder 6 til 17 · Alle køn · Opdateret 27. maj 2026 · NCT05781152Impact of Morning Light Therapy in IBD
- Mount Sinai Hospital, New York
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 13. mar. 2026 · NCT07207200A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, New York
- Mirador Therapeutics Selected Site, Rochester
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
- NYU Langone Health, New York
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 5. mar. 2026 · NCT06309017Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
- Icahn School of Medicine at Mount Sinai, New York
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 7. jan. 2026 · NCT06001450Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- New York University, New York
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 8. maj 2025 · NCT06750731Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.